Galenica AG engages in the provision of health care. The company is headquartered in Bern, Bern and currently employs 6,125 full-time employees. The company went IPO on 2017-04-07. The firm's business i divided into three business sectors: Retail, Products & Brands, and Services. The firm manages a locally established pharmacies network in Switzerland. The company develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Follow-Up Questions
GALNF hissesinin fiyat performansı nasıl?
GALNF 'in mevcut fiyatı $0 'dir, son işlem günde 0% decreased etti.
Galenica AG için ana iş temaları veya sektörler nelerdir?
Galenica AG Health Care endüstrisine ait ve sektör Health Care 'dir
Galenica AG 'in piyasa değerlemesi nedir?
Galenica AG 'in mevcut piyasa değerlemesi $0 'dir
Galenica AG al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 6 analist Galenica AG için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 4 al, 6 tut, 0 sat ve 2 güçlü sat içermektedir
